Vigene Biosciences, now part of Charles River, is a trusted leader in contract development and manufacturing solutions for gene therapy. With the recent acquisition by Charles River, Vigene Biosciences has undergone a complete rebranding and integration into Charles River's website. They offer Cell and Gene Therapy CDMO (Contract Development and Manufacturing Organization) solutions, including services for Cell Therapy, Viral Vector, and Plasmid DNA.

Their viral vector and plasmid products are designed to enhance and accelerate gene discovery research and programs. If you have any questions or need assistance with viral vector and plasmid solutions, Vigene Biosciences has a team of experts ready to help. Stay connected to the latest news and insights in the field by signing up for their newsletter.

Vigene Biosciences, now part of Charles River, is dedicated to providing innovative solutions for gene therapy and contributing to advancements in the field